Successful treatment with sumatriptan in a case with cyclic vomiting syndrome combined with 18q- syndrome.
The authors present a 14-year-old girl with 18q- syndrome combined with cyclic vomiting syndrome. Since the age of 5 years, she has been admitted to hospital 30 times. Despite trying many prophylactic treatments, no medication has inhibited the vomiting attacks successfully. Intranasal sumatriptan was effective at halting the vomiting attacks. This is the first case of 18q- syndrome combined with cyclic vomiting syndrome successfully treated with sumatriptan. This report may allow us to consider sumatriptan use in patients suffering from misery attack of cyclic vomiting syndrome combined with chromosomal abnormality of 18q- syndrome.
Department of Pediatrics, Tohoku University School of Medicine, Sendai, Miyagi, Japan. kakisuke@mui.biglobe.ne.jp
Yosuke
Y
Kakisaka
Keisuke
K
Wakusawa
Ikuko
I
Sato
Kazuhiro
K
Haginoya
Mitsugu
M
Uematsu
Mieko
M
Hirose
Mitsutoshi
M
Munakata
Tetsuo
T
Sato
Shigeru
S
Tsuchiya
D000281:Administration, Intranasal; D000293:Adolescent; D000302:Adrenal Cortex / Q000378:metabolism / Q000503:physiopathology; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D025063:Chromosome Disorders / Q000150:complications* / Q000235:genetics / Q000503:physiopathology; D002887:Chromosomes, Human, Pair 18 / Q000235:genetics; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008607:Intellectual Disability / Q000150:complications / Q000235:genetics / Q000503:physiopathology; D009421:Nervous System Malformations / Q000150:complications* / Q000235:genetics / Q000503:physiopathology; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage*; D018170:Sumatriptan / Q000008:administration & dosage*; D013577:Syndrome; D016896:Treatment Outcome; D014839:Vomiting / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology
D017366:Serotonin Receptor Agonists; D018170:Sumatriptan